Trial Profile
Multicenter, double blind, metronidazole controlled, dose range finding study of nitazoxanide in the treatment of Clostridium difficile colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2015
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary) ; Metronidazole
- Indications Clostridium difficile infections; Colitis
- Focus Therapeutic Use
- Sponsors Romark Laboratories
- 18 Jan 2007 New trial record.